HOT NEWS
Wednesday, 16 May 2012   
Merck total revenues increase 3.2% to € 2.6 billion
Merck KGaAThe Merck Group's first-quarter 2012 total revenues rose 3.2% to € 2,645 million compared to € 2,564 million in the first quarter of 2011. Sales for the Group increased 3.5% to € 2,564 million in first quarter compared to € 2,478 million in the year-ago quarter. This performance reflected organic sales growth of 1.2%, a 1.7% positive benefit from changes in foreign exchange rates and a 0.6% boost from acquisitions and divestments. The Group’s organic sales growth was entirely driven by the Merck Serono and Merck Millipore divisions during the quarter.
 
Tuesday, 15 May 2012   
Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe
AbbottAbbott (NYSE: ABT) today announced that the XIENCE PRIME™ and the XIENCE V® Everolimus Eluting Coronary Stent Systems have received CE Mark in Europe for the use of dual anti-platelet therapy (DAPT) for at least three months after stent implantation in patients with coronary artery disease. This is the shortest duration of DAPT for any major drug eluting stent (DES) in Europe.
 
Monday, 14 May 2012   
GSK statement on BBC Panorama broadcast: 'the truth about tax'
GlaxoSmithKlineGSK issued the following statement in response to the BBC Panorama programme related to Corporation Tax payments in the UK and Luxembourg broadcast tonight, Monday 14 May 2012. "GSK is very disappointed with this programme which was extremely misleading and lacking in context. Specifically, the programme's selective use of facts led to a misrepresentation of GSK's actions and a failure to recognize GSK's significant UK tax contribution.
 
Bookmark and Share

Banner

Research & Development

Finnish researchers discover genes inhibiting the spread of prostate cancer

The research team of Professor Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) screened dozens of...

A new target for developing anti-angiogenic and anti-tumoral therapies

Researchers from the Spanish National Cancer Research Centre (CNIO), led by Jorge L. Martínez-Torrecuadrada from the Proteomics Unit, have demonstrated...

Scientists discover new inflammatory target

Scientists from Queen Mary, University of London have found a new therapeutic target to combat inflammation. The research, published in...

Better Prognosis for Breast Cancer in Germany

How successful is the interdisciplinary treatment of breast cancer? Since 2003, the Breast Center at Heidelberg University Hospital has systematically...

More in: Research & Development

Conferences & Events

Doctors 2.0™ & You: Basil Strategies announces 10 Start-up Contest Finalists to Compet

Doctors 2.0 & You organizers of the 2nd edition today announced the finalists of the conference start-up contest. Ten start-ups based in 6 countries in Europe, Asia, and North America...

International industry gathering assumes leading position

The 23rd analytica, the International Trade Fair for Laboratory Technology, Analysis and Biotechnology, has opened its gates in Munich today with 1,026 exhibitors from 37 countries. This year's fair revolves...

analytica presents biotechnology highlights

From molecular-biology techniques to forensic DNA analysis: from April 17 - 20 analytica features in-depth information about the latest methods and techniques in laboratory technology, analysis and biotechnology. One of...

A look back at PHARM Connect Congress 2012

The 2nd edition of PHARM Connect, held in February 2012 in Budapest, confirmed again being the must-attend event for pharmaceutical and biotechnology sector professionals operating in Central and Eastern Europe....

MI Health Forum to provide the healthcare system with innovative prescriptions

24 - 25 May 2012, Barcelona, Spain. Finding different ways of providing better healthcare has never been more necessary. The growth and ageing of the population together with a restrictive...

More in: Conferences & Events

EC Pharmaceuticals

Commission proposes faster access to medicines for patients

News image

Medicines should enter the market faster. With this intention the European Commission has proposed today to streamline and reduce the duration of national decisions on pricing and reimbursement of medicines....

Pricing and reimbursement of medicines: Commission consults on EU transparency rules

News image

The European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites...

Call for proposals under the Innovative Medicines Initiative Joint Undertaking Third Call

News image

The Innovative Medicines Initiative (IMI) is a public-private partnership aiming to improve the drug development process. The European Commission's Seventh Framework Programme contributes EUR 1 billion to the IMI research...

An innovative pharmaceutical industry which meets the needs of society

News image

On the occasion of the Belgian Presidency's ministerial conference on innovation and solidarity in the field of pharmaceuticals, Commission Vice-President Antonio Tajani announced the launch of a process on corporate...

Awareness of the consequences of antibiotics overuse in the EU

News image

On 9 April the European Commission published two reports demonstrating the need for further progress in the European Union on the issue of anti microbial resistance. The first is a...

More in: European Commission

EMA News

Reflection paper on classification of advanced therapies released for public consultation

News image

The European Medicines Agency released a reflection paper on the classification of advanced-therapy medicines for public consultation. The paper clarifies the legal basis for the classification of medicines as advanced...

eSubmission Gateway now live for all applications for human medicines to the European Medicines Agency

News image

Following a successful pilot, the European Medicines Agency's eSubmission Gateway is now live for all applications for centralised marketing authorisations for human medicines. This is an important milestone in the...

Towards a robust global framework for conduct and oversight of clinical trials

News image

European Medicines Agency publishes reflection paper with practical guidance on the assurance of ethical and GCP standards in the conduct of clinical trials included in marketing authorisation applications submitted in...

European regulators propose way forward for publication of full clinical trial data

News image

A group of European regulators have set out a way forward for the publication of the results of clinical trials of authorised medicines. 'Open clinical trial data for all? A...

More in: EMA